Synthesis and germination activity study of novel strigolactam/strigolactone analogues

被引:4
|
作者
Ge, Yuhua [1 ]
Chen, Xingyue [1 ]
Khan, Shah Nawaz [2 ]
Jia, Shuhe [3 ]
Chen, Gang [2 ]
机构
[1] Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Shanghai Key Lab Mol Engn Chiral Drugs, Shanghai 200240, Peoples R China
[3] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Shenyang 110016, Peoples R China
关键词
Strigolactone; Strigolactam; SAR studies; Radical cyclization; C AH activation; INTRAMOLECULAR 2+2 CYCLOADDITION; PLANT DEVELOPMENT; STRIGOLACTONES; STIMULANT; STRIGA; STEREOISOMERS; INHIBITORS; GR24;
D O I
10.1016/j.tetlet.2022.154315
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Herein, we report an efficient and practical synthetic route to assemble novel highly-tens [5,5] trans- fused B/C strigolactam/strigolactone analogues along with cis-fused strigolactams. The key feature of our synthetic strategy includes palladium-catalyzed carboxylate-directed olefination of commercially available N-Boc phenylalanines followed by direct photocatalytic decarboxylative Giese cyclization. The SAR studies were conducted for the newly synthesized scaffolds to stimulate seed germination of Orobanche cumana. The trans-fused compounds showed better activity then the cis-fused compounds. However, the strigolactones 35/36 and 39/40 showed superior bioactivity than the GR245DS and GR244DO.(c) 2022 Elsevier Ltd. All rights reserved.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Design, Synthesis, and Anticancer Activity of Novel Fused Purine Analogues
    Hassan, A. Y.
    Sarg, M. T.
    Bayoumi, A. H.
    Kalaf, F. G. A.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2017, 54 (06) : 3458 - 3470
  • [42] Synthesis and immunomodulatory activity of novel amino acid analogues of fluoxetine
    Talati, Mamta N.
    Vemireddy, Sravanthi
    Seelam, Siva Deepthi
    Halmuthur, M. Sampath Kumar
    SYNTHETIC COMMUNICATIONS, 2023, 53 (10) : 731 - 743
  • [43] Synthesis and anticancer activity of novel quinoline-docetaxel analogues
    Chen, Ming
    Chen, Hui
    Ma, Jiangwei
    Liu, Xueying
    Zhang, Shengyong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (13) : 2867 - 2870
  • [44] Design, synthesis, and cytostatic activity of novel cyclic curcumin analogues
    Youssef, Dani
    Nichols, Christie E.
    Cameron, T. Stanley
    Balzarini, Jan
    De Clercq, Erik
    Jha, Amitabh
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (20) : 5624 - 5629
  • [45] Novel bleomycin analogues: Synthesis, antitumor activity, and interaction with DNA
    Xu, ZD
    Wang, M
    Xiao, SL
    Zhang, YJ
    Yang, M
    HELVETICA CHIMICA ACTA, 2004, 87 (11) : 2834 - 2841
  • [46] Synthesis of the novel analogues of dysidiolide and their structure-activity relationship
    Takahashi, M
    Dodo, K
    Sugimoto, Y
    Aoyagi, Y
    Yamada, Y
    Hashimoto, Y
    Shirai, R
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (22) : 2571 - 2574
  • [47] Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues
    Macchia, M
    Barontini, S
    Bertini, S
    Di Bussolo, V
    Fogli, S
    Giovannetti, E
    Grossi, E
    Minutolo, F
    Danesi, R
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) : 3994 - 4000
  • [48] Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues
    Zhou, Xiang
    Wang, Xiao-Bing
    Wang, Tao
    Kong, Ling-Yi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (17) : 8011 - 8021
  • [49] Synthesis of some novel oxadiazole and oxadiazoline analogues for their antiinflammatory activity
    Rajak, Harish
    Kharya, Murli Dhar
    Mishra, Pradeep
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (10): : 1757 - 1764
  • [50] Synthesis and biological evaluation of novel triptolide analogues for anticancer activity
    Zhou, Bing
    Miao, Zehong
    Deng, Gang
    Ding, Jian
    Yang, Yaxi
    Feng, Huijin
    Li, Yuanchao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (21) : 6217 - 6221